H. Mattie

发表

The relative efficacies of tobramycin and ciprofloxacin against pseudomonas aeruginosa in vitro and in normal and granulocytopenic mice

J. J. Hoogeterp, H. Mattie, P. Terporten, 2005, Infection.

Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.

W. Craig, B. Fantin, H. Mattie, 1989, The Journal of infectious diseases.

Determination of benzylpenicillin and probenecid in human body fluids by high-performance liquid chromatography.

H. Mattie, U. Tjaden, C. van Gulpen, 1986, Journal of chromatography.

Clinical Ototoxicity of Teicoplanin

J. Frijns, R. Bonnet, H. Mattie, 2004, The Annals of otology, rhinology, and laryngology.

A quantitative evaluation of pulmonary macrophage kinetics.

R. van Furth, H. Mattie, A. Blussé van oud Alblas, 1983, Cell and tissue kinetics.

Antibacterial activity of four cephalosporins in an experimental infection in relation to in vitro effect and pharmacokinetics.

H. Mattie, E. van Strijen, A. Krul, 1990, The Journal of infectious diseases.

Determinants of efficacy and toxicity of aminoglycosides.

W. Craig, H. Mattie, J. Pechère, 1989, The Journal of antimicrobial chemotherapy.

Role of granulocytes and monocytes in the prevention and therapy of experimental Staphylococcus epidermidis endocarditis in rabbits.

R. van Furth, H. Mattie, J. Thompson, 1985, The Journal of infection.

Pharmacokinetic and pharmacodynamic models of antimicrobial drugsIn vitro andIn vivo

H. Mattie, 1994, Infection.

Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection

W. Peetermans, J. J. Hoogeterp, H. Mattie, 1990, Antimicrobial Agents and Chemotherapy.

Comparison of in vivo and in vitro activities of antibiotics with different modes of action against a tolerant and a non-tolerant Staphylococcus aureus strain.

R. van Furth, J. J. Hoogeterp, H. Mattie, 1989, Scandinavian journal of infectious diseases.

The efficacy of rifampicin against Staphylococcus aureus in vitro and in an experimental infection in normal and granulocytopenic mice.

R. van Furth, J. J. Hoogeterp, H. Mattie, 1988, Scandinavian journal of infectious diseases.

Pharmacokinetics of flucloxacillin and cloxacillin in healthy subjects and patients on chronic intermittent haemodialysis.

H. Mattie, E. Nauta, 1975, British journal of clinical pharmacology.

The effect of co-trimoxazole on serum creatinine.

B. Dijkmans, H. Mattie, J. V. van Hooff, 1981, British journal of clinical pharmacology.

Clinical Pharmacokinetics of Cefamandole and Ceftazidime Administered by Continuous Intravenous Infusion

H. Mattie, L. Visser, P. J. van den Broek, 2003, Antimicrobial Agents and Chemotherapy.

Clinical pharmacokinetics of continuous intravenous administration of penicillins.

R. van Furth, H. Mattie, L. Visser, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy and nephrotoxicity of aminoglycosides

H. Mattie, 1991 .

Predictability of serum concentrations of aminoglycosides after haemodialysis

B. Dijkmans, H. Mattie, 2004, European Journal of Clinical Pharmacology.

Cefsulodin for the treatment of Pseudomonas infections--a study comparing cefsulodin and ticarcillin.

J. V. D. van der Meer, H. Mattie, A. Matze-van der Lans, 1989, The Netherlands journal of medicine.

Comparative pharmacodynamics and clinical pharmacokinetics of phenoxymethylpenicillin and pheneticillin.

D. Overbosch, R. van Furth, H. Mattie, 1985, British journal of clinical pharmacology.

Renal Clearance of Temocillin in Volunteers

D. Overbosch, H. Mattie, C. Gulpen, 2012, Drugs.

Flucloxacillin-associated liver damage.

B. Dijkmans, H. Mattie, J. V. van Hooff, 1982, The Netherlands journal of medicine.

Pharmacokinetics of oral fumarates in healthy subjects.

P. Nibbering, H. Thio, H. Mattie, 2004, British journal of clinical pharmacology.

Pharmacodynamics of antibiotics with respect to bacterial killing of and release of lipoteichoic acid by Streptococcus pneumoniae.

R. Nau, H. Mattie, J. V. van Dissel, 2005, The Journal of antimicrobial chemotherapy.

Influence of aminopenicillins on bacterial growth kinetics in vitro in comparison with the antibacterial effect in vivo

H. Mattie, G. Voet, 2005, Infection.

Therapeutic relevance of drug assays

H. Mattie, D. Breimer, F. Wolff, 1979 .

A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections.

R. van Furth, H. Mattie, J. V. van't Wout, 1988, The Journal of antimicrobial chemotherapy.

Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.

N. White, B. Angus, Y. Suputtamongkol, 2000, British journal of clinical pharmacology.

Rectal bioavailability of lidocaine in man: Partial avoidance of “first‐pass” metabolism

H. Mattie, D. Breimer, A. Boer, 1979, Clinical pharmacology and therapeutics.

Errors in the prediction of creatinine clearance in patients with rheumatoid arthritis.

M. Boers, F. Breedveld, H. Mattie, 1988, British journal of rheumatology.

Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.

N. White, B. Angus, Y. Suputtamongkol, 2000, British journal of clinical pharmacology.

Influence of cytostatic agents on the pulmonary defence of mice infected with Klebsiella pneumoniae and on the efficacy of treatment with ceftriaxone.

R. van Furth, H. Mattie, W. Calame, 1994, The Journal of infection.

The passage of cloxacillin into cerebrospinal fluid in the absence of meningitis.

H. Mattie, R. Thomeer, E. van Strijen, 1993, British journal of clinical pharmacology.

Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritis.

B. Dijkmans, B. E. van den Borne, F. Breedveld, 1995, British journal of clinical pharmacology.

Treatment of radiation sickness with pyridoxine hydrochloride in outpatients of a radiotherapy unit.

E. W. Emery, D. Laurence, H. Mattie, 1967, British medical journal.

Modification by monoamine oxidase inhibitors of the effect of some sympathomimetics on blood pressure.

D. Laurence, H. Mattie, B. Prichard, 1967, British medical journal.

Clinical Pharmacokinetics of Aztreonam

H. Mattie, 1994, Clinical pharmacokinetics.

Antibiotic efficacy in vivo predicted by in vitro activity.

H. Mattie, 2000, International journal of antimicrobial agents.

Pharmacokinetic and pharmacodynamic models of the antistaphylococcal effects of meropenem and cloxacillin in vitro and in experimental infection

H. Mattie, E. van Strijen, A. E. Douwes-Idema, 1997, Antimicrobial agents and chemotherapy.

Comparison of the antibacterial effects of cefepime and ceftazidime against Escherichia coli in vitro and in vivo

H. Mattie, E. van Strijen, M. V. van Ogtrop, 1992, Antimicrobial Agents and Chemotherapy.

Cloxacillin and nafcillin: serum binding and its relationship to antibacterial effect in mice.

H. Mattie, E. L. Noach, W. Goslings, 1973, The Journal of infectious diseases.

Blood levels of rifampicin, desacetylrifampicin and isoniazid during combined therapy.

H. Mattie, R. Mouton, J. de Wael, 1979, Journal of Antimicrobial Chemotherapy.

Active Metabolites of Isoxazolylpenicillins in Humans

H. Mattie, H. Thijssen, 1976, Antimicrobial Agents and Chemotherapy.

Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice

R. van Furth, H. Mattie, J. W. Van 't wout, 1989, Antimicrobial Agents and Chemotherapy.

Comparative study on the circulatory and respiratory effects of buprenorphine and methadone.

H. Mattie, J. Spierdijk, G. De Klerk, 1981, Acta anaesthesiologica Belgica.

Role of granulocytes in experimental Streptococcus sanguis endocarditis

R. van Furth, H. Mattie, F. Eulderink, 1982, Infection and immunity.

Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.

R. van Furth, H. Mattie, J. W. Van 't wout, 1990, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of vibunazole (BAY n 7133) administered orally to healthy subjects.

J. V. D. van der Meer, H. Mattie, J. V. van't Wout, 1985, The Journal of antimicrobial chemotherapy.

Brain abscess due to streptobacillus moniliformis and actinobacterium meyerii

B. Dijkmans, H. Mattie, G. Vielvoye, 1984, Infection.

Cefazolin and cephradine: relationship between antibacterial activity in vitro and in mice experimentally infected with Escherichia coli.

H. Mattie, M. Kunst, 1978, The Journal of infectious diseases.

Effect of Probenecid on the Apparent Volume of Distribution and Elimination of Cloxacillin

H. Mattie, E. Nauta, W. Goslings, 1974, Antimicrobial Agents and Chemotherapy.

Influence of etoposide and cyclophosphamide on the efficacy of cloxacillin and erythromycin in an experimental staphylococcal infection

R. van Furth, H. Mattie, W. Calame, 1989, Antimicrobial Agents and Chemotherapy.

Clinical Pharmacokinetics of Aztreonam

H. Mattie, 1988, Clinical pharmacokinetics.

The in vivo significance of tissue concentration

H. Mattie, M. Kunst, 1976, Infection.

Cefazolin and cephradine: Relationship between serum concentrations and tissue contents in mice

H. Mattie, M. Kunst, 2005, Infection.

Dicloxacillin and cloxacillin: Pharmacokinetics in healthy and hemodialysis subjects

H. Mattie, E. Nauta, Ernst H. Nauta, 1976, Clinical pharmacology and therapeutics.

QUANTITATIVE STUDY ON THE PRODUCTION AND KINETICS OF MONONUCLEAR PHAGOCYTES DURING AN ACUTE INFLAMMATORY REACTION

R. van Furth, H. Mattie, M. D. Diesselhoff-den Dulk, 1973, The Journal of experimental medicine.

Influence of cytostatic treatment on the efficacy of erythromycin and roxithromycin in a staphylococcal infection in mice.

H. Mattie, W. Calame, H. Guiot, 1990, Scandinavian journal of infectious diseases.

Decontaminating efficacy of ciprofloxacin in an animal model

H. Mattie, R. Furth, H. Guiot, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus

H. Mattie, P. J. van den Broek, A. P. Meyer, 1993, Antimicrobial Agents and Chemotherapy.

Probenecid and the antibacterial activity of cephradine in vivo.

H. Mattie, M. Kunst, 1978, The Journal of infectious diseases.

Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo

R. van Furth, H. Mattie, E. van Strijen, 1990, Antimicrobial Agents and Chemotherapy.

Kinetics of antimicrobial action.

H. Mattie, 1981, Reviews of infectious diseases.

The renal clearance of cefuroxime and ceftazidime and the effect of probenecid on their tubular excretion.

H. Mattie, C. Verhagen, E. van Strijen, 1994, British journal of clinical pharmacology.

A multicentre, randomized comparative study of 500 mg versus 1,000 mg ceftazidime t.d.s. for treatment of gram-negative infections

H. Mattie, M. Kunst, P. Jonker, 1995, Infection.

The effect of probenecid on the renal tubular excretion of benzylpenicillin.

D. Overbosch, H. Mattie, D Overbosch, 1988, British journal of clinical pharmacology.

Effect of penicillin G on Staphylococcus aureus phagocytosed by human monocytes.

R. van Furth, H. Mattie, P. J. van den Broek, 1986, The Journal of infectious diseases.

Short-term treatment of patients with chronic and recurrent urinary tract infections with co-trimoxazole

H. Mattie, H. J. Voogt, 1973, Urological Research.

The tubular excretion of benzylpenicillin in patients with cystic fibrosis.

H. Mattie, J. Bins, 1989, British journal of clinical pharmacology.

Evaluation of cloxacillin concentrations in plasma and muscle tissue during cardiopulmonary bypass.

B. Kullberg, R. van Furth, H. Mattie, 1991, Scandinavian journal of infectious diseases.

Comparison of the antibacterial efficacies of ampicillin and ciprofloxacin against experimental infections with Listeria monocytogenes in hydrocortisone-treated mice

R. van Furth, H. Mattie, E. van Strijen, 1992, Antimicrobial Agents and Chemotherapy.

Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis

D. Overbosch, H. Mattie, A. Polderman, 2004, European Journal of Clinical Pharmacology.

Absorption of Pivampicillin in Postoperative Patients

H. Mattie, M. Kunst, 1975, Antimicrobial Agents and Chemotherapy.

In vitro pharmacokinetics of anti-psoriatic fumaric acid esters

P. Nibbering, H. Thio, H. Mattie, 2004, BMC pharmacology.

Pharmacokinetics of cloxacillin in patients on chronic intermittent haemodialysis and in healthy subjects.

H. Mattie, E. Nauta, W. Goslings, 1973, Chemotherapy.

Fibrinolytic Treatment with Tissue-Type Plasminogen Activator (t-PA) of Streptococcus Sanguis Endocarditis

A. Buiting, H. Mattie, R. Furth, 1990 .

Effect of tissue-type plasminogen activator (t-PA) on the treatment with benzylpenicillin of rabbits with experimental Streptococcus sanguis endocarditis.

R. van Furth, A. Buiting, H. Mattie, 1989, The Journal of infectious diseases.

Effects of tissue-type plasminogen activator (t-PA) on Streptococcus sanguis-infected endocardial vegetations in vitro.

R. van Furth, A. Buiting, H. Mattie, 1988, The Journal of antimicrobial chemotherapy.

Effects of tissue-type plasminogen activator on Staphylococcus epidermidis--infected plasma clots as a model of infected endocardial vegetations.

R. van Furth, A. Buiting, H. Mattie, 1987, The Journal of antimicrobial chemotherapy.

Role of granulocytes in the prevention and therapy of experimental Streptococcus sanguis endocarditis in rabbits

R. van Furth, H. Mattie, J. Thompson, 1984, Antimicrobial Agents and Chemotherapy.

Minocycline treatment for rheumatoid arthritis: an open dose finding study.

F. Breedveld, H. Mattie, B. Dijkmans, 1990, The Journal of rheumatology.

Effect of cytostatic agents on the number of alveolar phagocytes and the efficacy of ceftriaxone in an experimental murine lung infection.

H. Mattie, W. Calame, 1991, The European respiratory journal.

Quantitative effect of granulocytes on antibiotic treatment of experimental staphylococcal infection

R. van Furth, J. J. Hoogeterp, H. Mattie, 1987, Antimicrobial Agents and Chemotherapy.

TNF-α and IL-10 production upon whole blood stimulation with a wide range of LPS concentrations: estimating an individual's dose- response characteristic described by the underlying receptor-ligand model

H. Mattie, J. Dissel, C. Martina, 2006 .

Contribution of alveolar phagocytes to antibiotic efficacy in an experimental lung infection with Streptococcus pneumoniae.

H. Mattie, W. Calame, M. van den Barselaar, 2001, The Journal of infection.

Influence ofEtoposide andCyclophosphamide on theEfficacy of Cloxacillin andErythromycin inanExperimental Staphylococcal Infection

H. Mattie, W. Calame, R. Vanfurth, 1989 .

Comparison of the antibacterial activity of azlocillin and ticarcillin in vitro and in irradiated neutropenic mice.

R. van Furth, H. Mattie, G. B. van der Voet, 1985, The Journal of antimicrobial chemotherapy.

The antibacterial activity of combinations of mecillinam and ampicillin in vitro and in normal and granulopenic mice.

R. van Furth, H. Mattie, G. B. van der Voet, 1983, Scandinavian journal of infectious diseases.

The relative potency of amoxycillin and ampicillin in vitro and in vivo.

H. Mattie, G. B. van der Voet, 1981, Scandinavian journal of infectious diseases.

Contingent negative variation, extraversion, reaction time and drug effects

E. Berretty, H. Mattie, P. Werre, 2001 .

Interaction between extraversion and drug-induced conditions as indicated by the contingent negative variation

C. Fortgens, E. Berretty, W. Sluiter, 1994, Biological Psychology.

The effect of glucocorticosteroids on the kinetics of pulmonary macrophages.

R. van Furth, H. Mattie, A. Blussé van oud Alblas, 1981, Journal of the Reticuloendothelial Society.

The penetration of erythromycin into human bronchial mucosa.

J. J. Hoogeterp, H. Mattie, J. Hermans, 1987, British journal of clinical pharmacology.

Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice.

B. Dijkmans, J. Hermans, R. van Furth, 1984, The Journal of antimicrobial chemotherapy.

Efficacy of rifamycin SV and vancomycin againstBacteroides fragilis in vitro and in experimentally infected mice

B. Dijkmans, H. Mattie, Jyotsna Vaishnav-Nair, 2005, Current Microbiology.

Efficacy of amoxycillin and benzylpenicillin combined with clavulanic acid against Bacteroides fragilis in vitro and in experimentally infected mice.

B. Dijkmans, H. Mattie, J. Vaishnav, 1985, Scandinavian Journal of Infectious Diseases.

The effect of antibacterial drugs on the growth kinetics ofBacteroides in vitro

H. Mattie, J. Vaishnav, 1983, Current Microbiology.

Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.

B. Dijkmans, H. Mattie, J. Vaishnav, 1985, Chemotherapy.

Animal models in antibacterial drug research.

H. Mattie, 1984, Journal of Antimicrobial Chemotherapy.

Prolonged bleeding time during azlocillin therapy.

B. Dijkmans, J. V. D. van der Meer, H. Mattie, 1980, The Journal of antimicrobial chemotherapy.

Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins

R. van Furth, H. Mattie, M. V. van Ogtrop, 1991, Antimicrobial Agents and Chemotherapy.

The effects on ventilation of ketorolac in comparison with morphine

H. Mattie, A. Burm, J. Spierdijk, 2004, European Journal of Clinical Pharmacology.

Relationships between antimicrobial effect and area under the concentration-time curve as a basis for comparison of modes of antibiotic administration: meropenem bolus injections versus continuous infusions

H. Mattie, A. Firsov, 1997, Antimicrobial Agents and Chemotherapy.

Effectiveness of netilmicin and tobramycin against Pseudomonas aeruginosa in vitro and in an experimental tissue infection in mice.

J. J. Hoogeterp, H. Mattie, B. G. Moffie, 1993, The Journal of antimicrobial chemotherapy.

Activity of erythromycin and clindamycin in an experimental Staphylococcus aureus infection in normal and granulocytopenic mice. A comparative in vivo and in vitro study.

R. van Furth, J. J. Hoogeterp, H. Mattie, 1993, Scandinavian journal of infectious diseases.

Comparative StudyoftheEffects ofFourCephalosporins against Escherichia coli InVitro andInVivo

H. Mattie, 1990 .

The effects of a depressant and a stimulant drug on the contingent negative variation

H. Mattie, R. H. C. Janssen, H. Mattie, 1978, Biological Psychology.

A mathematical description of short-term effects of β-lactam antibiotics on bacterial growth in vitro

H. Mattie, 1978, Current Microbiology.

Intracellular activity of trovafloxacin against Staphylococcus aureus.

H. Mattie, P. J. van den Broek, E. van Strijen, 1999, The Journal of antimicrobial chemotherapy.

The relation between plasma and tissue concentrations of antibiotics. Description of a method

J. J. Hoogeterp, H. Mattie, J. Hermans, 1987, Journal of Pharmacokinetics and Biopharmaceutics.

Antibiotic-Induced Lipopolysaccharide (LPS) Release from Salmonella typhi: Delay between Killing by Ceftazidime and Imipenem and Release of LPS

H. Mattie, J. V. van Dissel, K. Kwappenberg, 1998, Antimicrobial Agents and Chemotherapy.

Diffusion of cloxacillin into synovial tissue.

P. Rozing, H. Mattie, E. van Strijen, 1992, British journal of clinical pharmacology.

Active metabolites of isoxazolylpencillins in humans.

H. Mattie, H. Thijssen, 1976, Antimicrobial agents and chemotherapy.

[Side effects of minocycline in the treatment of acne vulgaris].

H. Mattie, M. Bastiaens, R. V. van Leeuwen, 1997, Nederlands tijdschrift voor geneeskunde.

A new soluble acetylsalicylic acid derivative in the treatment of postoperative pain.

H. Mattie, J. Spierdijk, J. Hermans, 1974, British journal of anaesthesia.

The Influence of the Thyroid Function on the Metabolic Rate of Prothrombin, Factor VII, and Factor X in the Rat

W. Hermens, H. Mattie, J. Veltkamp, 1976, Thrombosis and Haemostasis.

Saturation of the tubular excretion of beta-lactam antibiotics.

H. Mattie, J. Bins, 1988, British Journal of Clinical Pharmacology.

Levels of azithromycin and alpha-1 acid glycoprotein in serum in patients with community-acquired pneumonia

H. Mattie, P. J. van den Broek, R. Bohte, 1995, Antimicrobial agents and chemotherapy.

In vitro pharmacokinetics of anti-psoriatic fumaric acid esters

P. Nibbering, H. Mattie, E. van Strijen, 2004, BMC pharmacology.

Antibacterial effect of etoposide in vitro

R. van Furth, H. Mattie, W. Calame, 1988, Antimicrobial Agents and Chemotherapy.

Intracellular activity of trovafloxacin against Staphylococcus aureus.

H. Mattie, P. J. van den Broek, T. G. A. Koot, 1999, The Journal of antimicrobial chemotherapy.